Cannara Biotech, Inc. · TSX:LOVE

Cannara Biotech — Investor Presentation (November 2022)

44 slides from Cannara Biotech's investor presentation, Nov 24, 2022

  1. Slide 1: Premium-Grade Cannabis at Scale

    TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB PREMIUM-GRADE CANNABIS AT SCALE INVESTOR DECK Q4 FISCAL 2022 (AS OF AUGUST 31, 2022)

  2. Slide 2: General Disclaimer

    GENERAL DISCLAIMER This corporate presentation dated November 24, 2022 (the “Presentation”) has been prepared by management of Cannara Biotech Inc. (the “Company” or “Cannara”) and is based on public information. This Presentation does not constitute an offer to sell to any person, or a general offe

  3. Slide 3: Forward-Looking Statement

    FORWARD-LOOKING STATEMENT This presentation contains “forward-looking information” within the meaning of Canadian securities legislation. This information and these statements, referred to herein as “forward-looking statements” are made as of the date of this presentation or as of the date of the ef

  4. Slide 4: Executive Summary

    EXECUTIVE SUMMARY

  5. Slide 5: Corporate Overview

    CORPORATE OVERVIEW We are a vertically integrated Canadian Licensed Producer of premium-grade cannabis and cannabis-derivative products • Canada’s third largest producer based on square footage. Two mega facilities based in Quebec, Canada spanning over 1.6 million square feet. • Currently serving co

  6. Slide 6: Key Investor Considerations

    KEY INVESTOR CONSIDERATIONS Well Capitalized, Fast-Growing Business Strategic Brand Portfolio • Cannabis revenues grew from $5.7M in Q1 of 2022 to $11.1M in • Three flagship in-house brands. Q4 of 2022 and approximately 7,300 kg of cannabis were sold • Brand partnership with Exotic Genetix. in 2022

  7. Slide 7: Corporate Milestones

    CORPORATE MILESTONES MARCH 2018 JULY 2018 JULY 2018 FEBRUARY JANUARY 2020 2019 FEBRUARY 2021 APRIL 2021 JUNE 2021 $ TSXV IDEA FACILITY CAPITAL CULTIVATION SQDC RETAIL LAUNCH TSXV LISTING VALLEYFIELD March 2018, idea is Potential 625,000 sf Launches 17,000 sq Retail debut of its ACQUISITION Cannara r

  8. Slide 8: Operations

    OPERATIONS

  9. Slide 9: Farnham Facility

    FARNHAM FACILITY FARNHAM, QUEBEC LEASED 150,000 sq. ft. 625,000 sq. ft. facility provides 181,000 sq. ft. of LEASED cannabis operation. 294,000 sq. ft. PHASE 1 Fully automated with biomonitoring sensors in every 181,000 sq. ft. 8,000 Kg grow room to ensure optimal conditions and increased plant yiel

  10. Slide 10: Farnham Facility

    FARNHAM FACILITY FARNHAM, QUEBEC IRRIGATION HUMIDITY LIGHTING TEMPERATURE NUTRIENTS FULL AUTOMATION State of the art indoor cultivation, allows us to produce up to 8,000 kg annually, for which demand has already exceeded supply from the Quebec market alone. Q4 FY 2022 | 10

  11. Slide 11: Valleyfield Facility

    VALLEYFIELD FACILITY SALABERRY-DE-VALLEYFIELD, QUEBEC Acquired in June 2021 from The Green Organic Dutchman for $27 million in cash plus certain deposit requirements, the Facility was built for an estimated construction cost of $250 million. Occupies 1,033,506 sq. ft. on 3,000,000 sq. ft. of land. O

  12. Slide 12: Valleyfield Facility

    VALLEYFIELD FACILITY SALABERRY-DE-VALLEYFIELD, QUEBEC PHASE 1 24 INDEPENDENT GROWING ZONES MEASURING 25,000 SQ.FT EACH 1,033,506 sq. ft. facility The completely automated facility is equipped with cutting edge technology including: : LED LIGHTING - FULLY BLACKED-OUT ROOF - AUTOMATED TABLES • 578,022

  13. Slide 13: The Principals of Our Success

    THE PRINCIPALS OF OUR SUCCESS QUALITY ACCESSIBILITY BRAND CULTURE Premium “AAAA” cannabis Disruptive low pricing Grassroot brand culture Hang dried, slow cured Aligned with legacy market Transparency At scale Ideal for your everyday consumers Consumers become ambassadors Q4 FY 2022 | 13

  14. Slide 14: Premium-Grade Cannabis at Scale

    PREMIUM-GRADE CANNABIS AT SCALE Delivering a premium quality product is at the heart of our ethos, resulting in high cannabinoid content and rich flavourful cannabis. Our cannabis employs methods used in the most sophisticated markets in the world such as California; cultivated from: RARE GENETICS H

  15. Slide 15: Accessibility

    ACCESSIBILITY

  16. Slide 16: Production Assets: Competitive Landscape

    PRODUCTION ASSETS COMPETITIVE LANDSCAPE CANADIAN PRODUCERS CANNARA’S ESTIMATED PRODUCTION ASSET SQUARE FOOTAGE QUARTERLY PRODUCTION CAPACITY IN KG Village Farms 2,200,000 sf 16,000 kg Aphria/Tilray 2,150,000 sf 14,000 kg Cannara 1,650,000 sf Canopy Growth 1,514,000 sf 12,000 kg HEXO 1,300,000 sf 10,

  17. Slide 17: Why Quebec

    WHY QUEBEC AVERAGE ELECTRICITY RATES BY PROVINCE IN CENTS PER KW HOUR 11.3¢/kWh 10.7¢/kWh 9.7¢/kWh 8.9¢/kWh Quebec has the lowest electricity rates in 4.2¢/kWh 5.5¢/kWh 7.8¢/kWh Canada (QC: 4.2¢/kWh vs. ONT: 11.3¢/kWh). QC MB BC SK AB NS ON Quebec has the highest barriers of entry 685 150 345 114 re

  18. Slide 18: Cannara Pricing Strategy

    CANNARA PRICING STRATEGY CANNARA PRICING STRATEGY QUEBEC MARKET OVERVIEW PRICE - QUALITY MATRIX $19.30 /3.5G QUALITY AA OTHER BRANDS SKIMMING PREMIUM HIGH CANOPY GHOST DROPS BEST VALUE HEXO COOKIES ORGANIGRAM QWEST $25.60 /3.5G RUBICON (SIMPLY BARE) QUALITY AAAA CANNARA PRICE LOW COST PENETRATION $4

  19. Slide 19: Our Value and Brands

    OUR VALUE _ANDE BRANDS ~ ae a

  20. Slide 20: Our Unique Value Proposition

    OUR UNIQUE VALUE PROPOSITION Cannara is giving consumers what they want—premium quality at accessible, value- based pricing fit for frequent cannabis consumers and new entrants alike. Our “AAAA” quality cannabis and disruptive low pricing have resulted in high demand for our products. In addition to

  21. Slide 21: Portfolio of Brands

    PORTFOLIO OF BRANDS Our portfolio consists of three flagship brands with distinctive identity and purpose, each filling a white space in Canada’s current cannabis market without compromising quality. All three brands offer premium-grade cannabis, hang-dried and slow-cured to preserve the flower’s na

  22. Slide 22: Tribal

    TRIBAL BRAND STORY Tribal delivers uncompromised premium-grade cannabis to consumers who have a deep relationship with cannabis. From pheno-hunting rare genetics to unfolding each strain’s lineage and flavor profiles, Tribal is a journey not a destination. POSITIONING Tribal appeals to those who hav

  23. Slide 23: Nugz

    NUGZ BRAND STORY Nugz is a cult-worthy movement committed to abundance, quality and value. Nugz offers a disruptive product line designed for long-time consumers who have a sharp sense for product quality on the lookout for better value. POSITIONING Nugz is a brand created for frequent cannabis user

  24. Slide 24: Orchid CBD

    ORCHID CBD BRAND STORY Orchid CBD is a wellness brand dedicated to providing rare strains of CBD-dominant, terpene-rich, trichome covered, oversized dried flowers that deliver softer, blissful experiences without compromising quality and flavors. POSITIONING Orchid CBD is a CBD-dominant brand of can

  25. Slide 25: Exclusive US Brand Partnership in Canada

    EXCLUSIVE US BRAND PARTNERSHIP IN CANADA 50-Time US Award-Winning Seed Breeder EXOTIC GENETIX is partnering with CANNARA In addition to three flagship brands, Cannara has an exclusive license to use, market, sell and distribute Exotic Genetix branded products throughout Canada. In addition, Exotic G

  26. Slide 26: Growth Strategy

    GROWTH STRATEGY

  27. Slide 27: 2022 Growth Initiatives Met

    2022 GROWTH INITIATIVES MET 1. INCREASED CANNABIS SUPPLY Cannara had a 2022 annual objective and achieved it before end of year to activate 6 of its 24 25,000 square foot cultivation zones in its Valleyfield facility. Subsequent to year-end, a 7th growing zone was activated, As at the date of this r

  28. Slide 28: 1. Increase Cannabis Supply

    1. INCREASE CANNABIS SUPPLY CANNABIS PRODUCTION & REVENUE GROWTH TRAJECTORY AS VALLEYFIELD PRODUCTION SCALES UP CANNABIS NET REVENUE IN $ MILLIONS AND KG SOLD CANNABIS PRODUCTION (TRIMMED BUDS) IN KG 8000 kg $12M $9.7 7000 kg 2,755 KG $10M $8.2 6000 kg 2,350 KG $8M 5000 kg $5.8 $5.3 $5.4 2,870 KG $5

  29. Slide 29: 2-3. New Product Offering

    2-3. NEW PRODUCT OFFERING Q1 FY23 2 NEW GENETICS FOR FY 2022 LIVE RESIN 510 VAPE CART GELATO MINT CUBAN LINX TERPLE POWER SHERB GALACTIC RUNTZ TRIPLE BURGER CUSTOM 510 VAPE CART BATTERY INDICA SATIVA HYBRID INDICA INDICA INDICA LIVE RESIN FULL SPECTRUM EXTRACT THC: 21% - 27% THC: 23% - 29% THC: 21%

  30. Slide 30: 4. Increase Market Share

    4. INCREASE MARKET SHARE MARKET EXPANSION STRATEGY Cannara has created lean and profitable operations proven to produce premium cannabis at scale and at competitive prices. With ability to produce up to 125,000 kg of premium cannabis at full scale, Cannara will expand its products offering across al

  31. Slide 31: 5. Continued Positive EBITDA

    5. CONTINUED POSITIVE EBITDA Since its retail launch in the prior year, Cannara has reported positive EBITDA for the last six quarters while expanding its operations significantly in 2022. With the start of the cultivation activities at the Valleyfield Facility over the past year, Cannara has been a

  32. Slide 32: Financials

    Y *e < e ¢Y 5 < u Zz LL

  33. Slide 33: Selected Financial Highlights

    SELECTED FINANCIAL HIGHLIGHTS Q4 2022 FINANCIAL OUTLOOK TRAILING TWELVE MONTH CUMULATIVE REVENUES Cash $12.1M $ 34 000 000 Current assets $41M Current debt $11.9M Working capital 1 $29.1M $ 28 000 000 Total assets $125.6M NET assets $66.7M $ 21 000 000 Quarterly revenue $12M 2 Cannabis Gross margin

  34. Slide 34: Total Net Revenues by Quarter

    TOTAL NET REVENUES BY QUARTER TOTAL NET REVENUES ANALYSIS BY QUARTER IN $ MILLIONS $12M - TOTAL NET REVENUE - GROSS MARGIN 1 $12 $10,1 $10M $8M $7,4 $7,2 $7M $6,5 $6,6 $6M $4,8 $5M $3,7 $4M $3,5 $3,4 $3,0 $3M $2,6 $2,3 $2M $1,4 $1,3 $1M $0,5 $0M 36% 58% 49% 53% 46% 36% 37% 40% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q

  35. Slide 35: Q4 2022 Detailed Highlights

    Q4 2022 DETAILED HIGHLIGHTS FOOTNOTES 1 Gross revenue included revenue from sale of goods, net of excise taxes, services revenue and lease revenues. 2 Gross profit before fair value adjustments % is determined as Gross profit before fair value adjustments divided by Total revenues. 3 Gross profit is

  36. Slide 36: Quarterly Detailed Highlights

    QUARTERLY DETAILED HIGHLIGHTS 1 Adjusted EBITDA and free cash flow are non-GAAP financial performance measures. A reconciliation of theses measures is presented in the MD&A available on www.sedar.com. 2 Gross profit before fair value adjustments % is determined as Gross profit before fair value adju

  37. Slide 37: Notable Achievements Q4 2022 and Subsequent

    NOTABLE ACHIEVEMENTS Q4 2022 AND SUBSEQUENT TO QUARTER HIGHLIGHTS JULY 2022 Approval obtained to become a licensed vendor to the British Columbia Cannabis Store and acceptance of 7 SKUS for listing First shipments of product were done in September 2022 AUGUST 2022 Signing of exclusive brand partners

  38. Slide 38: Leadership Team

    LEADERSHIP TEAM

  39. Slide 39: Executive Leadership Team

    EXECUTIVE LEADERSHIP TEAM ZOHAR KRIVOROT NICHOLAS SOSIAK AVI KRIVOROT CHAIRMAN & CEO CFO CTO Zohar is an entrepreneur who has launched Nicholas is a CPA with an entrepreneurial spirit Avi has been in the information technology several successful businesses. He has founded, and passion for the Cannab

  40. Slide 40: Executive Management Team

    EXECUTIVE MANAGEMENT TEAM ISSAM BEN MOUSSA NOEMI FOLLAIN ANTHONY MANOUK VP PRODUCTION & EXPERIMENTATION VP FINANCE GM & VP COMPLIANCE Issam is an engineer in Agronomy & Noemi is a Chartered Professional Anthony is an accomplished business biotechnology and has a PhD in plant Accountant and have 8 ye

  41. Slide 41: Executive Management Team Continued

    EXECUTIVE MANAGEMENT TEAM CONTINUED SCOTT CARROLL VP MARKETING & SALES Scott joins the Cannara team with extensive global brand strategy experience in the highly regulated pharmaceutical and cannabis industries, holding a PhD in Genetics and an BRIAN SHERMAN NICOLAS DUPUIS Executive MBA. Growing bra

  42. Slide 42: Board of Directors

    BOARD OF DIRECTORS ZOHAR KRIVOROT MARY DUROCHER CHAIRMAN & CEO DIRECTOR Mary has been involved in the cannabis industry since the Zohar is an entrepreneur who has launched several infancy of the Marihuana for Medical Purposes successful businesses. He has founded, advised and Regulations introductio

  43. Slide 43: Positioned for National Success

    IN SUMMARY Well capitalized, fast-growing business with an Operating with strong margins and with a established history of execution. focus on positive EBITDA, free cash flow and organic growth through capital reinvestment Offering customers the highest value products at disruptive low prices. State

  44. Slide 44: Thank You

    TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB THANK YOU www.cannara.ca investors.cannara.ca www.instagram.com/cannarabiotech www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blvd, Suite 200 1144 Boulevard Magenta E 1175 Boulevard Gérard-Cadieux Saint-Laur

Cannara Biotech — Investor Presentation (November 2022) on 6ix